157 related articles for article (PubMed ID: 30106653)
1. A RAT by Another Name: 21
Riley MF
Am J Law Med; 2018 May; 44(2-3):291-308. PubMed ID: 30106653
[No Abstract] [Full Text] [Related]
2. Rejuvenating Regenerative Medicine Regulation.
Charo RA; Sipp D
N Engl J Med; 2018 Feb; 378(6):504-505. PubMed ID: 29320637
[No Abstract] [Full Text] [Related]
3. Is the FDA regulating the practice of medicine?
Aicher RH
Aesthet Surg J; 2013 Mar; 33(3):452-5. PubMed ID: 23515389
[No Abstract] [Full Text] [Related]
4. Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges.
Hyun I
J Law Med Ethics; 2010; 38(2):277-85. PubMed ID: 20579251
[TBL] [Abstract][Full Text] [Related]
5. FDA challenges stem-cell clinic.
Cyranoski D
Nature; 2010 Aug; 466(7309):909. PubMed ID: 20725009
[No Abstract] [Full Text] [Related]
6. 21
Paradise J
Am J Law Med; 2018 May; 44(2-3):309-327. PubMed ID: 30106644
[TBL] [Abstract][Full Text] [Related]
7. The Food and Drug Administration, regenerative sciences, and the regulation of autologous stem cell therapies.
von Tigerstrom B
Food Drug Law J; 2011; 66(4):479-506, i. PubMed ID: 24505826
[TBL] [Abstract][Full Text] [Related]
8. Unproven stem cell interventions: A global public health problem requiring global deliberation.
Master Z; Matthews KRW; Abou-El-Enein M
Stem Cell Reports; 2021 Jun; 16(6):1435-1445. PubMed ID: 34107243
[TBL] [Abstract][Full Text] [Related]
9. FDA's claims over stem cells upheld.
Cyranoski D
Nature; 2012 Aug; 488(7409):14. PubMed ID: 22859178
[No Abstract] [Full Text] [Related]
10. Reflection on the enactment and impact of safety laws for regenerative medicine in Japan.
Takashima K; Morrison M; Minari J
Stem Cell Reports; 2021 Jun; 16(6):1425-1434. PubMed ID: 34019814
[TBL] [Abstract][Full Text] [Related]
11. Adult stem cell therapies walk the line.
DeFrancesco L
Nat Biotechnol; 2012 Aug; 30(8):739-41. PubMed ID: 22871705
[No Abstract] [Full Text] [Related]
12. 21
Kinney ED
Am J Law Med; 2018 May; 44(2-3):269-290. PubMed ID: 30106646
[No Abstract] [Full Text] [Related]
13. Foreword: A compendium on latest developments in stem cell research and cell therapy applications.
Koka PS; Khanna A
J Stem Cells; 2009; 4(2):81-3. PubMed ID: 20232593
[No Abstract] [Full Text] [Related]
14. Fast-Forward to the Frightening Future: How the 21
Orlando AW; Rosoff AJ
Am J Law Med; 2018 May; 44(2-3):253-268. PubMed ID: 30106645
[No Abstract] [Full Text] [Related]
15. The dangers of unregulated stem-cell marketing.
Mohammadi D
Lancet; 2017 Oct; 390(10105):1823-1824. PubMed ID: 28870714
[No Abstract] [Full Text] [Related]
16. New Japanese initiatives on stem cell therapies.
Konomi K; Tobita M; Kimura K; Sato D
Cell Stem Cell; 2015 Apr; 16(4):350-2. PubMed ID: 25842974
[TBL] [Abstract][Full Text] [Related]
17. On the Road (to a Cure?)--Stem-Cell Tourism and Lessons for Gene Editing.
Charo RA
N Engl J Med; 2016 Mar; 374(10):901-3. PubMed ID: 26863030
[No Abstract] [Full Text] [Related]
18. The social production of evidence: regenerative medicine and the 21st Century Cures Act.
Hogle LF; Das A
Regen Med; 2017 Sep; 12(6):581-586. PubMed ID: 28976283
[No Abstract] [Full Text] [Related]
19. The 21
Kassirer JP
Am J Law Med; 2018 May; 44(2-3):157-160. PubMed ID: 30106655
[No Abstract] [Full Text] [Related]
20. Cells as drugs?: regulating the future of medicine.
Pivarnik G
Am J Law Med; 2014; 40(2-3):298-321. PubMed ID: 25211998
[No Abstract] [Full Text] [Related]
[Next] [New Search]
